Physiologically active derivatives of esterastin

Chemistry of carbon compounds – Miscellaneous organic carbon compounds – C-metal

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435123, 435886, C07D30512

Patent

active

042028248

ABSTRACT:
Three, new physiologically active derivatives of esterastin are now provided, which inhibit the activity of esterase similarly to the parent esterastin and further exhibit a higher inhibiting activity against cholesterol esterase than the parent esterastin. These three new derivatives are tetrahydroesterastin which is produced by catalytic hydrogenation of esterastin; 3,5-di-hydroxy-2-hexylhexadeca-7,10-dienoic 1,3-lactone which is produced by alkaline hydrolysis of esterastin; and 3,5-di-hydroxy-2-hexylhexadecanoic 1,3-lactone which is produced either by alkaline hydrolysis of said tetrahydroesterastin or by catalytic hydrogenation of the product of the alkaline hydrolysis of esterastin.

REFERENCES:
Umezawa et al., The Journal of Antibiotics 31, No. 6, 639-641 (Jun. 1978).
Kondo et al., The Journal of Antibiotics 31, No. 8, 797-800 (Aug. 1978).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Physiologically active derivatives of esterastin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Physiologically active derivatives of esterastin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Physiologically active derivatives of esterastin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-929427

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.